Evidence map›Paper›PMID 34359843›Full record

ArticleCells2021

Extracellular Vesicles Derived from Endothelial Progenitor Cells Protect Human Glomerular Endothelial Cells and Podocytes from Complement- and Cytokine-Mediated Injury.

Davide Medica, Rossana Franzin, Alessandra Stasi, Giuseppe Castellano, Massimiliano Migliori, Vincenzo Panichi, Federico Figliolini, Loreto Gesualdo, Giovanni Camussi, Vincenzo Cantaluppi

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. IL-6 and diabetic kidney disease.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Davide MedicaDepartment of Translational Medicine, University of Piemonte Orientale (UPO), via Solaroli 17, 28100 Novara, Italy.ORCID 0000-0002-6171-8919
Rossana FranzinNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Alessandra StasiNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.ORCID 0000-0003-3652-3623
Giuseppe CastellanoNephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0002-0153-3795
Massimiliano MiglioriNephrology and Dialysis Unit, Versilia Hospital, 55041 Camaiore, Italy.
Vincenzo PanichiNephrology and Dialysis Unit, Versilia Hospital, 55041 Camaiore, Italy.
Federico FiglioliniDepartment of Medical Sciences, University of Torino, 10126 Torino, Italy.
Loreto GesualdoNephrology, Dialysis and Transplantation Unit, Department of Emergency and Organ Transplantation, University of Bari, 70124 Bari, Italy.
Giovanni CamussiDepartment of Medical Sciences, University of Torino, 10126 Torino, Italy.ORCID 0000-0003-2795-232X
Vincenzo CantaluppiDepartment of Translational Medicine, University of Piemonte Orientale (UPO), via Solaroli 17, 28100 Novara, Italy.ORCID 0000-0002-4120-3555
University of Bari Aldo Moro · ITOspedale Versilia · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Turin · ITUniversity of Foggia · IT

Funding

Ministero dell'Istruzione, dell'Università e della Ricerca Departments of Excellence 2018-2022Università degli Studi del Piemonte Orientale AGING Project-Department of Translational Medicine
6 · The paper itself

Abstract

Glomerulonephritis are renal inflammatory processes characterized by increased permeability of the Glomerular Filtration Barrier (GFB) with consequent hematuria and proteinuria. Glomerular endothelial cells (GEC) and podocytes are part of the GFB and contribute to the maintenance of its structural and functional integrity through the release of paracrine mediators. Activation of the complement cascade and pro-inflammatory cytokines (CK) such as Tumor Necrosis Factor α (TNF-α) and Interleukin-6 (IL-6) can alter GFB function, causing acute glomerular injury and progression toward chronic kidney disease. Endothelial Progenitor Cells (EPC) are bone-marrow-derived hematopoietic stem cells circulating in peripheral blood and able to induce angiogenesis and to repair injured endothelium by releasing paracrine mediators including Extracellular Vesicles (EVs), microparticles involved in intercellular communication by transferring proteins, lipids, and genetic material (mRNA, microRNA, lncRNA) to target cells. We have previously demonstrated that EPC-derived EVs activate an angiogenic program in quiescent endothelial cells and renoprotection in different experimental models. The aim of the present study was to evaluate in vitro the protective effect of EPC-derived EVs on GECs and podocytes cultured in detrimental conditions with CKs (TNF-α/IL-6) and the complement protein C5a. EVs were internalized in both GECs and podocytes mainly through a L-selectin-based mechanism. In GECs, EVs enhanced the formation of capillary-like structures and cell migration by modulating gene expression and inducing the release of growth factors such as VEGF-A and HGF. In the presence of CKs, and C5a, EPC-derived EVs protected GECs from apoptosis by decreasing oxidative stress and prevented leukocyte adhesion by inhibiting the expression of adhesion molecules (ICAM-1, VCAM-1, E-selectin). On podocytes, EVs inhibited apoptosis and prevented nephrin shedding induced by CKs and C5a. In a co-culture model of GECs/podocytes that mimicked GFB, EPC-derived EVs protected cell function and permeselectivity from inflammatory-mediated damage. Moreover, RNase pre-treatment of EVs abrogated their protective effects, suggesting the crucial role of RNA transfer from EVs to damaged glomerular cells. In conclusion, EPC-derived EVs preserved GFB integrity from complement- and cytokine-induced damage, suggesting their potential role as therapeutic agents for drug-resistant glomerulonephritis.

Indexed as

ApoptosisCell MovementCell ProliferationCoculture TechniquesComplement C5aEndothelial Progenitor CellsExtracellular VesiclesGene Expression RegulationHepatocyte Growth FactorHumansIntercellular Adhesion Molecule-1Interleukin-6L-SelectinMicroRNAsNeovascularization, PhysiologicParacrine CommunicationComplement C5aHepatocyte Growth FactorHGF protein, humanICAM1 protein, humanIL6 protein, humanIntercellular Adhesion Molecule-1Interleukin-6L-SelectinMicroRNAsReactive Oxygen SpeciesTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1Vascular Endothelial Growth Factor AVEGFA protein, humanangiogenesiscomplement cascadecytokinesendothelial progenitor cellsextracellular vesiclesglomerular endothelial cellsglomerulonephritisinflammationpodocytes

Identifiers

PMID34359843
PMCPMC8304261
OpenAlexW3177097629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.